

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.58203765 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.23139841 |
| 3 | negative regulation of interleukin-12 production (GO:0032695) | 4.82523014 |
| 4 | response to peptidoglycan (GO:0032494) | 4.67735984 |
| 5 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.61024259 |
| 6 | NIK/NF-kappaB signaling (GO:0038061) | 4.59044027 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.52234899 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.52234899 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.52234899 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.52234899 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.52234899 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 4.52234899 |
| 13 | granulocyte activation (GO:0036230) | 4.37286487 |
| 14 | neutrophil activation (GO:0042119) | 4.35731107 |
| 15 | positive regulation of interferon-alpha production (GO:0032727) | 4.33779131 |
| 16 | positive regulation of antigen processing and presentation (GO:0002579) | 4.28813843 |
| 17 | response to muramyl dipeptide (GO:0032495) | 4.09535923 |
| 18 | regulation of interferon-alpha production (GO:0032647) | 4.08784493 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 4.04240230 |
| 20 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.01868751 |
| 21 | natural killer cell mediated immunity (GO:0002228) | 4.01868751 |
| 22 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.01844416 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.00006677 |
| 24 | positive regulation of interleukin-12 production (GO:0032735) | 3.91013205 |
| 25 | myeloid dendritic cell differentiation (GO:0043011) | 3.86561885 |
| 26 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.83984282 |
| 27 | regulation of activation of Janus kinase activity (GO:0010533) | 3.82790970 |
| 28 | T-helper 1 type immune response (GO:0042088) | 3.82677073 |
| 29 | type I interferon signaling pathway (GO:0060337) | 3.81108580 |
| 30 | cellular response to type I interferon (GO:0071357) | 3.81108580 |
| 31 | positive regulation of type 2 immune response (GO:0002830) | 3.77769010 |
| 32 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.77487115 |
| 33 | response to type I interferon (GO:0034340) | 3.76933645 |
| 34 | regulation of antigen processing and presentation (GO:0002577) | 3.74224526 |
| 35 | macrophage activation involved in immune response (GO:0002281) | 3.73889273 |
| 36 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.73668547 |
| 37 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.68989514 |
| 38 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.64791536 |
| 39 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.62814771 |
| 40 | detection of molecule of bacterial origin (GO:0032490) | 3.61352956 |
| 41 | negative regulation of cell killing (GO:0031342) | 3.61161188 |
| 42 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.61161188 |
| 43 | respiratory burst (GO:0045730) | 3.55402808 |
| 44 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.54209906 |
| 45 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.52117040 |
| 46 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.50293173 |
| 47 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.50293173 |
| 48 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.48192027 |
| 49 | myeloid dendritic cell activation (GO:0001773) | 3.45952819 |
| 50 | regulation of mast cell degranulation (GO:0043304) | 3.44010906 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.43758089 |
| 52 | regulation of RIG-I signaling pathway (GO:0039535) | 3.43741536 |
| 53 | detection of other organism (GO:0098543) | 3.42146457 |
| 54 | cellular extravasation (GO:0045123) | 3.41506772 |
| 55 | glycosphingolipid catabolic process (GO:0046479) | 3.41336654 |
| 56 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.38845605 |
| 57 | oligosaccharide catabolic process (GO:0009313) | 3.36501536 |
| 58 | regulation of hypersensitivity (GO:0002883) | 3.34674220 |
| 59 | microglial cell activation (GO:0001774) | 3.32645775 |
| 60 | positive regulation of mast cell activation (GO:0033005) | 3.31147364 |
| 61 | dendritic cell differentiation (GO:0097028) | 3.28229476 |
| 62 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.28070193 |
| 63 | monocyte chemotaxis (GO:0002548) | 3.27756071 |
| 64 | superoxide anion generation (GO:0042554) | 3.27569174 |
| 65 | negative regulation of interleukin-17 production (GO:0032700) | 3.22892529 |
| 66 | regulation of mononuclear cell migration (GO:0071675) | 3.21594775 |
| 67 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.21268332 |
| 68 | response to host immune response (GO:0052572) | 3.21268332 |
| 69 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.21190762 |
| 70 | leukocyte mediated cytotoxicity (GO:0001909) | 3.20667481 |
| 71 | positive regulation of heat generation (GO:0031652) | 3.19798244 |
| 72 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.19472704 |
| 73 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.18471034 |
| 74 | reactive oxygen species biosynthetic process (GO:1903409) | 3.16432469 |
| 75 | cytokine secretion (GO:0050663) | 3.16106910 |
| 76 | detection of external biotic stimulus (GO:0098581) | 3.15973234 |
| 77 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.15750408 |
| 78 | regulation of interleukin-12 production (GO:0032655) | 3.15572349 |
| 79 | positive regulation of interferon-beta production (GO:0032728) | 3.15483533 |
| 80 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.14194817 |
| 81 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.14176927 |
| 82 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.13175246 |
| 83 | detection of bacterium (GO:0016045) | 3.12639048 |
| 84 | response to interferon-alpha (GO:0035455) | 3.11265873 |
| 85 | growth hormone receptor signaling pathway (GO:0060396) | 3.10901187 |
| 86 | glycolipid catabolic process (GO:0019377) | 3.08323230 |
| 87 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.07740765 |
| 88 | B cell mediated immunity (GO:0019724) | 3.06194192 |
| 89 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.05681726 |
| 90 | regulation of fever generation (GO:0031620) | 3.03710721 |
| 91 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.03319387 |
| 92 | defense response to protozoan (GO:0042832) | 3.02326140 |
| 93 | germinal center formation (GO:0002467) | 3.00584996 |
| 94 | myeloid cell activation involved in immune response (GO:0002275) | 3.00009534 |
| 95 | cellular response to interferon-gamma (GO:0071346) | 2.99634233 |
| 96 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.99000440 |
| 97 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.98954573 |
| 98 | regulation of leukocyte degranulation (GO:0043300) | 2.98659514 |
| 99 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.98236028 |
| 100 | negative regulation of viral genome replication (GO:0045071) | 2.98078780 |
| 101 | regulation of mast cell activation (GO:0033003) | 2.97256856 |
| 102 | amino sugar catabolic process (GO:0046348) | 2.96446449 |
| 103 | regulation of gamma-delta T cell activation (GO:0046643) | 2.96367426 |
| 104 | cellular response to interferon-beta (GO:0035458) | 2.95951660 |
| 105 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.94371734 |
| 106 | positive regulation of leukocyte degranulation (GO:0043302) | 2.93111156 |
| 107 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.93082171 |
| 108 | regulation of T cell tolerance induction (GO:0002664) | 2.92756004 |
| 109 | regulation of macrophage chemotaxis (GO:0010758) | 2.91445200 |
| 110 | macrophage activation (GO:0042116) | 2.91342915 |
| 111 | lymphocyte mediated immunity (GO:0002449) | 2.90793374 |
| 112 | detection of biotic stimulus (GO:0009595) | 2.90674659 |
| 113 | cellular response to interferon-alpha (GO:0035457) | 2.89767359 |
| 114 | regulation of podosome assembly (GO:0071801) | 2.89228143 |
| 115 | regulation of chemokine biosynthetic process (GO:0045073) | 2.89192609 |
| 116 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.89017693 |
| 117 | cellular response to zinc ion (GO:0071294) | 2.88268372 |
| 118 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.87191894 |
| 119 | eosinophil chemotaxis (GO:0048245) | 2.85323112 |
| 120 | regulation of monocyte chemotaxis (GO:0090025) | 2.84308051 |
| 121 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.84255365 |
| 122 | response to host defenses (GO:0052200) | 2.83738106 |
| 123 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.83738106 |
| 124 | response to host (GO:0075136) | 2.83738106 |
| 125 | regulation of immunoglobulin secretion (GO:0051023) | 2.83625726 |
| 126 | regulation of tolerance induction (GO:0002643) | 2.82892576 |
| 127 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.82652124 |
| 128 | myeloid leukocyte activation (GO:0002274) | 2.81148322 |
| 129 | positive regulation of mast cell degranulation (GO:0043306) | 2.80797128 |
| 130 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.80797128 |
| 131 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.80592281 |
| 132 | positive regulation of humoral immune response (GO:0002922) | 2.80254899 |
| 133 | response to protozoan (GO:0001562) | 2.79566081 |
| 134 | peptide catabolic process (GO:0043171) | 2.79351343 |
| 135 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.75641912 |
| 136 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.75378633 |
| 137 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.73317168 |
| 138 | ceramide catabolic process (GO:0046514) | 2.72949734 |
| 139 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.70032197 |
| 140 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.69891121 |
| 141 | regulation of vitamin metabolic process (GO:0030656) | 2.64687359 |
| 142 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.59401452 |
| 143 | regulation of type 2 immune response (GO:0002828) | 2.57635546 |
| 144 | response to thyroid hormone (GO:0097066) | 2.57135537 |
| 145 | neutrophil chemotaxis (GO:0030593) | 2.50818618 |
| 146 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.50795120 |
| 147 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.50412067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.92168650 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.60555832 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.76648990 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.69313492 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.19876696 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.18297065 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.08814203 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.75920038 |
| 9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.67657442 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.65232215 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.49042742 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.31110711 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.89902929 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.72584105 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.51756639 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42953740 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.42293509 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.42106417 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.38853973 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.31426671 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.26682484 |
| 22 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.14051029 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.10720912 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.99907131 |
| 25 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.94107424 |
| 26 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.84435484 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.72536932 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.71798595 |
| 29 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.70536314 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69055572 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.66130441 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.63637417 |
| 33 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63042766 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.56332192 |
| 35 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.54893655 |
| 36 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.51186161 |
| 37 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.49186073 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48681153 |
| 39 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.47810451 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.46803384 |
| 41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.45261026 |
| 42 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43505359 |
| 43 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.40367687 |
| 44 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.40006328 |
| 45 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.39561613 |
| 46 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38656731 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38195997 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.37212240 |
| 49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36281359 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.34387566 |
| 51 | MAF_26560356_Chip-Seq_TH1_Human | 1.31219767 |
| 52 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30785481 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27739550 |
| 54 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.27110631 |
| 55 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25506613 |
| 56 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.20677614 |
| 57 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.19067710 |
| 58 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.18717441 |
| 59 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18435678 |
| 60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18338683 |
| 61 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.18108475 |
| 62 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15913196 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.13817010 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13059059 |
| 65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12930194 |
| 66 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.12012735 |
| 67 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.11882257 |
| 68 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.11176702 |
| 69 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.11176702 |
| 70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10931760 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10491238 |
| 72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09259420 |
| 73 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09068386 |
| 74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.08413280 |
| 75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.08413280 |
| 76 | MYB_26560356_Chip-Seq_TH1_Human | 1.07575002 |
| 77 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07330774 |
| 78 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07020462 |
| 79 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06874318 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06744113 |
| 81 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06041413 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05205352 |
| 83 | CJUN_26792858_Chip-Seq_BT549_Human | 1.04100119 |
| 84 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.04045363 |
| 85 | UTX_26944678_Chip-Seq_JUKART_Human | 1.02374026 |
| 86 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01465826 |
| 87 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98925060 |
| 88 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98224931 |
| 89 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96713367 |
| 90 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96491973 |
| 91 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.96402687 |
| 92 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95861923 |
| 93 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95231314 |
| 94 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95112260 |
| 95 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93929115 |
| 96 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93812675 |
| 97 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92651655 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91645426 |
| 99 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.91528725 |
| 100 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89571549 |
| 101 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89385107 |
| 102 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.87648747 |
| 103 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87357109 |
| 104 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.86501153 |
| 105 | MAF_26560356_Chip-Seq_TH2_Human | 0.85710372 |
| 106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83845180 |
| 107 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.82427620 |
| 108 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82000118 |
| 109 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.81852772 |
| 110 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.80905216 |
| 111 | SA1_27219007_Chip-Seq_Bcells_Human | 0.80756013 |
| 112 | P68_20966046_ChIP-Seq_HELA_Human | 0.80022422 |
| 113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79522764 |
| 114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79272570 |
| 115 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.79237992 |
| 116 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79141889 |
| 117 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.78758307 |
| 118 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.78514020 |
| 119 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.77749189 |
| 120 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.76599839 |
| 121 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75702635 |
| 122 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.73910428 |
| 123 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.71803207 |
| 124 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71618992 |
| 125 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.65650760 |
| 126 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.65635570 |
| 127 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.64309777 |
| 128 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.63705340 |
| 129 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.63619344 |
| 130 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.63051159 |
| 131 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.62815399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.83107187 |
| 2 | MP0002148_abnormal_hypersensitivity_rea | 3.85866310 |
| 3 | MP0009785_altered_susceptibility_to | 3.80784003 |
| 4 | MP0003436_decreased_susceptibility_to | 3.65677382 |
| 5 | MP0004510_myositis | 3.23352464 |
| 6 | MP0000685_abnormal_immune_system | 3.19193841 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 3.19094043 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.04664915 |
| 9 | MP0001790_abnormal_immune_system | 2.92768261 |
| 10 | MP0005387_immune_system_phenotype | 2.92768261 |
| 11 | * MP0002419_abnormal_innate_immunity | 2.85944975 |
| 12 | * MP0005025_abnormal_response_to | 2.77591054 |
| 13 | MP0003303_peritoneal_inflammation | 2.76380296 |
| 14 | MP0005671_abnormal_response_to | 2.63208856 |
| 15 | MP0006082_CNS_inflammation | 2.62979444 |
| 16 | MP0002254_reproductive_system_inflammat | 2.61056365 |
| 17 | MP0003724_increased_susceptibility_to | 2.47828915 |
| 18 | * MP0002452_abnormal_antigen_presenting | 2.46716695 |
| 19 | MP0001800_abnormal_humoral_immune | 2.38812741 |
| 20 | * MP0002723_abnormal_immune_serum | 2.32827567 |
| 21 | MP0002139_abnormal_hepatobiliary_system | 2.29954906 |
| 22 | MP0002006_tumorigenesis | 2.21615260 |
| 23 | MP0005058_abnormal_lysosome_morphology | 2.08928281 |
| 24 | * MP0001819_abnormal_immune_cell | 2.05893191 |
| 25 | MP0005310_abnormal_salivary_gland | 2.04926795 |
| 26 | MP0009764_decreased_sensitivity_to | 2.02720570 |
| 27 | MP0002166_altered_tumor_susceptibility | 2.01204810 |
| 28 | * MP0002420_abnormal_adaptive_immunity | 2.00690167 |
| 29 | MP0001853_heart_inflammation | 1.98613985 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.95819835 |
| 31 | MP0004947_skin_inflammation | 1.94517268 |
| 32 | MP0005451_abnormal_body_composition | 1.88979650 |
| 33 | MP0008004_abnormal_stomach_pH | 1.86205924 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.77917562 |
| 35 | MP0002277_abnormal_respiratory_mucosa | 1.71081254 |
| 36 | MP0002405_respiratory_system_inflammati | 1.70921097 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.68039172 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.66831419 |
| 39 | * MP0003448_altered_tumor_morphology | 1.64562748 |
| 40 | MP0001348_abnormal_lacrimal_gland | 1.56350341 |
| 41 | * MP0008469_abnormal_protein_level | 1.54897522 |
| 42 | MP0003075_altered_response_to | 1.52085515 |
| 43 | MP0002998_abnormal_bone_remodeling | 1.51169932 |
| 44 | MP0005167_abnormal_blood-brain_barrier | 1.44194223 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.43692682 |
| 46 | * MP0000716_abnormal_immune_system | 1.41873850 |
| 47 | MP0005365_abnormal_bile_salt | 1.40315769 |
| 48 | MP0000858_altered_metastatic_potential | 1.37110485 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.35457388 |
| 50 | MP0003806_abnormal_nucleotide_metabolis | 1.33586896 |
| 51 | MP0000343_altered_response_to | 1.31664376 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.30481602 |
| 53 | MP0005410_abnormal_fertilization | 1.29783373 |
| 54 | MP0009278_abnormal_bone_marrow | 1.28826375 |
| 55 | MP0002163_abnormal_gland_morphology | 1.28418587 |
| 56 | MP0000604_amyloidosis | 1.27948918 |
| 57 | MP0009840_abnormal_foam_cell | 1.27456736 |
| 58 | MP0002398_abnormal_bone_marrow | 1.24243512 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.24196254 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.24196254 |
| 61 | MP0008260_abnormal_autophagy | 1.23425813 |
| 62 | MP0004782_abnormal_surfactant_physiolog | 1.21985767 |
| 63 | MP0005076_abnormal_cell_differentiation | 1.18250506 |
| 64 | MP0003453_abnormal_keratinocyte_physiol | 1.17531611 |
| 65 | MP0003195_calcinosis | 1.17505198 |
| 66 | MP0003300_gastrointestinal_ulcer | 1.16696342 |
| 67 | MP0005166_decreased_susceptibility_to | 1.14800756 |
| 68 | MP0001346_abnormal_lacrimal_gland | 1.11237690 |
| 69 | MP0003172_abnormal_lysosome_physiology | 1.11019255 |
| 70 | MP0003091_abnormal_cell_migration | 1.10218396 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 1.09488814 |
| 72 | MP0003566_abnormal_cell_adhesion | 1.09299586 |
| 73 | * MP0002429_abnormal_blood_cell | 1.06364811 |
| 74 | MP0003329_amyloid_beta_deposits | 1.03503482 |
| 75 | MP0005164_abnormal_response_to | 1.02902830 |
| 76 | MP0002132_abnormal_respiratory_system | 1.00731816 |
| 77 | MP0005390_skeleton_phenotype | 0.99051866 |
| 78 | MP0003186_abnormal_redox_activity | 0.98208242 |
| 79 | MP0000689_abnormal_spleen_morphology | 0.96933752 |
| 80 | MP0009763_increased_sensitivity_to | 0.95365790 |
| 81 | MP0002009_preneoplasia | 0.93707436 |
| 82 | MP0000920_abnormal_myelination | 0.93274348 |
| 83 | MP0000465_gastrointestinal_hemorrhage | 0.91739865 |
| 84 | MP0002722_abnormal_immune_system | 0.89474570 |
| 85 | MP0003828_pulmonary_edema | 0.89295573 |
| 86 | MP0001958_emphysema | 0.87692399 |
| 87 | MP0002877_abnormal_melanocyte_morpholog | 0.87240110 |
| 88 | MP0008438_abnormal_cutaneous_collagen | 0.85057523 |
| 89 | MP0002933_joint_inflammation | 0.85005652 |
| 90 | MP0006054_spinal_hemorrhage | 0.84238252 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.83213665 |
| 92 | MP0004019_abnormal_vitamin_homeostasis | 0.83181836 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.82441062 |
| 94 | MP0010307_abnormal_tumor_latency | 0.80958433 |
| 95 | MP0001663_abnormal_digestive_system | 0.79385869 |
| 96 | MP0000678_abnormal_parathyroid_gland | 0.79036672 |
| 97 | MP0005275_abnormal_skin_tensile | 0.76702695 |
| 98 | MP0000767_abnormal_smooth_muscle | 0.76117572 |
| 99 | MP0000627_abnormal_mammary_gland | 0.75738601 |
| 100 | MP0001881_abnormal_mammary_gland | 0.74558989 |
| 101 | MP0003690_abnormal_glial_cell | 0.74325133 |
| 102 | MP0005023_abnormal_wound_healing | 0.74306192 |
| 103 | MP0010352_gastrointestinal_tract_polyps | 0.74166344 |
| 104 | MP0003866_abnormal_defecation | 0.71903746 |
| 105 | * MP0000249_abnormal_blood_vessel | 0.71467422 |
| 106 | MP0001873_stomach_inflammation | 0.70488636 |
| 107 | MP0005083_abnormal_biliary_tract | 0.70466319 |
| 108 | MP0000609_abnormal_liver_physiology | 0.70040590 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 0.69745461 |
| 110 | MP0000371_diluted_coat_color | 0.68093016 |
| 111 | MP0005257_abnormal_intraocular_pressure | 0.65961237 |
| 112 | MP0005647_abnormal_sex_gland | 0.65847651 |
| 113 | MP0008875_abnormal_xenobiotic_pharmacok | 0.65363161 |
| 114 | MP0005165_increased_susceptibility_to | 0.65000581 |
| 115 | MP0001879_abnormal_lymphatic_vessel | 0.64826609 |
| 116 | MP0005085_abnormal_gallbladder_physiolo | 0.64343943 |
| 117 | MP0002295_abnormal_pulmonary_circulatio | 0.64240648 |
| 118 | MP0001851_eye_inflammation | 0.61890143 |
| 119 | MP0003879_abnormal_hair_cell | 0.61633956 |
| 120 | MP0003795_abnormal_bone_structure | 0.60587225 |
| 121 | MP0002118_abnormal_lipid_homeostasis | 0.59152555 |
| 122 | MP0002332_abnormal_exercise_endurance | 0.58865303 |
| 123 | MP0003183_abnormal_peptide_metabolism | 0.58180838 |
| 124 | MP0004883_abnormal_blood_vessel | 0.57766982 |
| 125 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.57589914 |
| 126 | MP0004858_abnormal_nervous_system | 0.57327900 |
| 127 | MP0003763_abnormal_thymus_physiology | 0.56393319 |
| 128 | MP0005379_endocrine/exocrine_gland_phen | 0.56245438 |
| 129 | MP0003045_fibrosis | 0.55981050 |
| 130 | MP0001216_abnormal_epidermal_layer | 0.54957145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.60537616 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.58556558 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.29810295 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.38083113 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 4.99725629 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.96326411 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.59672036 |
| 8 | Autoimmune thrombocytopenia (HP:0001973) | 4.56351791 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.32599306 |
| 10 | Increased IgM level (HP:0003496) | 4.28881457 |
| 11 | Orchitis (HP:0100796) | 4.22700251 |
| 12 | Optic neuritis (HP:0100653) | 4.15227289 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 4.15227289 |
| 14 | Myositis (HP:0100614) | 4.01588542 |
| 15 | Gingivitis (HP:0000230) | 3.96675215 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 3.89549386 |
| 17 | Recurrent skin infections (HP:0001581) | 3.81026611 |
| 18 | Thick nail (HP:0001805) | 3.80401725 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.70820139 |
| 20 | Glomerulonephritis (HP:0000099) | 3.61581673 |
| 21 | Vasculitis (HP:0002633) | 3.60811802 |
| 22 | Myocardial infarction (HP:0001658) | 3.59138680 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 3.55197248 |
| 24 | Purpura (HP:0000979) | 3.43715424 |
| 25 | Recurrent viral infections (HP:0004429) | 3.35623671 |
| 26 | Prostate neoplasm (HP:0100787) | 3.35498048 |
| 27 | Stomatitis (HP:0010280) | 3.32275661 |
| 28 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.30475088 |
| 29 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.30475088 |
| 30 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.30475088 |
| 31 | Interstitial pulmonary disease (HP:0006530) | 3.27851763 |
| 32 | Obstructive lung disease (HP:0006536) | 3.27051780 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 3.27051780 |
| 34 | Basal ganglia calcification (HP:0002135) | 3.25872344 |
| 35 | Tetraparesis (HP:0002273) | 3.24459011 |
| 36 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.13292996 |
| 37 | Pustule (HP:0200039) | 3.11908682 |
| 38 | Periodontitis (HP:0000704) | 3.11425089 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 3.10803447 |
| 40 | Chronic otitis media (HP:0000389) | 3.10424461 |
| 41 | Pulmonary infiltrates (HP:0002113) | 3.10122047 |
| 42 | Axonal loss (HP:0003447) | 3.03927221 |
| 43 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.92588739 |
| 44 | Hypergammaglobulinemia (HP:0010702) | 2.90570774 |
| 45 | Increased serum ferritin (HP:0003281) | 2.90407515 |
| 46 | Arterial thrombosis (HP:0004420) | 2.84345408 |
| 47 | Hematochezia (HP:0002573) | 2.82959879 |
| 48 | Mutism (HP:0002300) | 2.80256215 |
| 49 | Nephritis (HP:0000123) | 2.78424528 |
| 50 | Urticaria (HP:0001025) | 2.73020072 |
| 51 | Cellulitis (HP:0100658) | 2.72011166 |
| 52 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.70241645 |
| 53 | Osteolytic defects of the hand bones (HP:0009699) | 2.69933218 |
| 54 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.69933218 |
| 55 | Neurofibrillary tangles (HP:0002185) | 2.69531715 |
| 56 | Leukocytosis (HP:0001974) | 2.68815070 |
| 57 | Petechiae (HP:0000967) | 2.67576606 |
| 58 | Peritonitis (HP:0002586) | 2.63300290 |
| 59 | Premature loss of primary teeth (HP:0006323) | 2.55695949 |
| 60 | Malnutrition (HP:0004395) | 2.53201349 |
| 61 | Esophageal varix (HP:0002040) | 2.48929044 |
| 62 | Recurrent cutaneous fungal infections (HP:0011370) | 2.47659320 |
| 63 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.47659320 |
| 64 | Gingival bleeding (HP:0000225) | 2.47272294 |
| 65 | Eosinophilia (HP:0001880) | 2.43983517 |
| 66 | Metaphyseal irregularity (HP:0003025) | 2.43647895 |
| 67 | Abnormality of glycolipid metabolism (HP:0010969) | 2.43502259 |
| 68 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.43502259 |
| 69 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.43502259 |
| 70 | Nasal polyposis (HP:0100582) | 2.39688130 |
| 71 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.38055220 |
| 72 | Hemoptysis (HP:0002105) | 2.38032043 |
| 73 | Abnormality of iron homeostasis (HP:0011031) | 2.37484306 |
| 74 | Keratoconjunctivitis sicca (HP:0001097) | 2.35690918 |
| 75 | Hydroxyprolinuria (HP:0003080) | 2.35500933 |
| 76 | Abnormality of proline metabolism (HP:0010907) | 2.35500933 |
| 77 | Asymmetric septal hypertrophy (HP:0001670) | 2.34592042 |
| 78 | Meningitis (HP:0001287) | 2.34305988 |
| 79 | Osteomyelitis (HP:0002754) | 2.31575151 |
| 80 | Recurrent pneumonia (HP:0006532) | 2.30720802 |
| 81 | Progressive visual loss (HP:0000529) | 2.29720825 |
| 82 | Vertebral compression fractures (HP:0002953) | 2.28965985 |
| 83 | Disinhibition (HP:0000734) | 2.27945069 |
| 84 | Increased IgE level (HP:0003212) | 2.25486596 |
| 85 | Progressive neurologic deterioration (HP:0002344) | 2.25218761 |
| 86 | Bone pain (HP:0002653) | 2.25115764 |
| 87 | Porencephaly (HP:0002132) | 2.24208050 |
| 88 | Episodic fever (HP:0001954) | 2.23745227 |
| 89 | Abnormality of the nasal mucosa (HP:0000433) | 2.23196596 |
| 90 | Keratoconjunctivitis (HP:0001096) | 2.20495819 |
| 91 | Abnormality of complement system (HP:0005339) | 2.20063144 |
| 92 | Autoimmune hemolytic anemia (HP:0001890) | 2.18312323 |
| 93 | Epistaxis (HP:0000421) | 2.15645883 |
| 94 | Prolonged bleeding time (HP:0003010) | 2.14046840 |
| 95 | Retinal atrophy (HP:0001105) | 2.12371433 |
| 96 | Amyloidosis (HP:0011034) | 2.10932553 |
| 97 | Recurrent lower respiratory tract infections (HP:0002783) | 2.09866846 |
| 98 | Abnormality of the pericardium (HP:0001697) | 2.09617840 |
| 99 | Dysostosis multiplex (HP:0000943) | 2.09184537 |
| 100 | Emphysema (HP:0002097) | 2.06894141 |
| 101 | Pulmonary embolism (HP:0002204) | 2.06233299 |
| 102 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.06141734 |
| 103 | Neuronal loss in central nervous system (HP:0002529) | 2.05921487 |
| 104 | Granulocytopenia (HP:0001913) | 2.05466310 |
| 105 | Pulmonary artery stenosis (HP:0004415) | 2.04063603 |
| 106 | Anorexia (HP:0002039) | 2.03392949 |
| 107 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.02939689 |
| 108 | Cerebral inclusion bodies (HP:0100314) | 2.02280653 |
| 109 | Loss of speech (HP:0002371) | 2.01254735 |
| 110 | Arthralgia (HP:0002829) | 2.00066534 |
| 111 | Fatigue (HP:0012378) | 1.99827493 |
| 112 | Spontaneous hematomas (HP:0007420) | 1.99232459 |
| 113 | Complement deficiency (HP:0004431) | 1.98624700 |
| 114 | Joint swelling (HP:0001386) | 1.98460841 |
| 115 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.98273060 |
| 116 | Hepatosplenomegaly (HP:0001433) | 1.97962137 |
| 117 | Diminished motivation (HP:0000745) | 1.97783217 |
| 118 | Polyneuropathy (HP:0001271) | 1.97704982 |
| 119 | Chest pain (HP:0100749) | 1.97499696 |
| 120 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.97174105 |
| 121 | Apathy (HP:0000741) | 1.96725808 |
| 122 | Gangrene (HP:0100758) | 1.96301818 |
| 123 | Encephalitis (HP:0002383) | 1.96135373 |
| 124 | Nuclear cataract (HP:0100018) | 1.95837298 |
| 125 | Skin ulcer (HP:0200042) | 1.94530724 |
| 126 | Abnormality of T cell number (HP:0011839) | 1.94114048 |
| 127 | Thrombocytosis (HP:0001894) | 1.93290610 |
| 128 | Anhidrosis (HP:0000970) | 1.93157662 |
| 129 | Abnormality of eosinophils (HP:0001879) | 1.92342932 |
| 130 | Acne (HP:0001061) | 1.91056539 |
| 131 | Xanthomatosis (HP:0000991) | 1.89822940 |
| 132 | Pathologic fracture (HP:0002756) | 1.88868466 |
| 133 | Thin bony cortex (HP:0002753) | 1.88509285 |
| 134 | Polycythemia (HP:0001901) | 1.86834425 |
| 135 | Colitis (HP:0002583) | 1.85454083 |
| 136 | Mucopolysacchariduria (HP:0008155) | 1.85304918 |
| 137 | Vertigo (HP:0002321) | 1.83858198 |
| 138 | Increased CSF protein (HP:0002922) | 1.82452292 |
| 139 | Peripheral demyelination (HP:0011096) | 1.81985768 |
| 140 | Restrictive lung disease (HP:0002091) | 1.79482473 |
| 141 | Dementia (HP:0000726) | 1.79285493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.67755483 |
| 2 | RIPK4 | 4.05785655 |
| 3 | TBK1 | 3.87414488 |
| 4 | TYK2 | 3.53035336 |
| 5 | IKBKB | 3.35911585 |
| 6 | IKBKE | 3.04784172 |
| 7 | PBK | 3.00403407 |
| 8 | BLK | 2.90443721 |
| 9 | JAK3 | 2.88404470 |
| 10 | MAP3K13 | 2.82408272 |
| 11 | IRAK4 | 2.77865610 |
| 12 | IRAK3 | 2.53386210 |
| 13 | CHUK | 2.44445594 |
| 14 | JAK1 | 2.29917702 |
| 15 | DDR2 | 2.28019835 |
| 16 | PIM2 | 2.09873053 |
| 17 | TAOK1 | 1.92275714 |
| 18 | KIT | 1.70683507 |
| 19 | NEK9 | 1.67942139 |
| 20 | MST4 | 1.64026377 |
| 21 | EPHB1 | 1.59307953 |
| 22 | TAOK2 | 1.52801549 |
| 23 | BMPR2 | 1.50659050 |
| 24 | PRPF4B | 1.49516319 |
| 25 | CDC42BPA | 1.45290464 |
| 26 | CSK | 1.35812005 |
| 27 | BMX | 1.30917407 |
| 28 | FGFR4 | 1.27408195 |
| 29 | EPHA3 | 1.22005274 |
| 30 | ACVR1B | 1.21889658 |
| 31 | TXK | 1.19837094 |
| 32 | JAK2 | 1.17772073 |
| 33 | PDPK1 | 1.16117572 |
| 34 | ERN1 | 1.14738073 |
| 35 | TGFBR2 | 1.14486618 |
| 36 | ZAP70 | 1.14075503 |
| 37 | PIM1 | 1.12956417 |
| 38 | MST1R | 1.12077172 |
| 39 | MAP4K1 | 1.10816483 |
| 40 | FES | 1.05046697 |
| 41 | RPS6KA4 | 1.04210771 |
| 42 | ABL2 | 1.01738498 |
| 43 | SYK | 1.01719708 |
| 44 | FGFR3 | 0.98715842 |
| 45 | TNK2 | 0.98014683 |
| 46 | CSF1R | 0.96616181 |
| 47 | IRAK1 | 0.92888922 |
| 48 | HCK | 0.92817612 |
| 49 | TRIB3 | 0.92611377 |
| 50 | RIPK1 | 0.92288425 |
| 51 | PDK1 | 0.90287289 |
| 52 | ARAF | 0.88894008 |
| 53 | EIF2AK2 | 0.88801750 |
| 54 | MATK | 0.88769674 |
| 55 | TRPM7 | 0.87400518 |
| 56 | LCK | 0.86614477 |
| 57 | FGR | 0.86156420 |
| 58 | SIK1 | 0.83808098 |
| 59 | LYN | 0.82821284 |
| 60 | STK4 | 0.81377585 |
| 61 | TAOK3 | 0.81357551 |
| 62 | MAP3K3 | 0.78851679 |
| 63 | GRK6 | 0.77807347 |
| 64 | EPHA2 | 0.76994151 |
| 65 | BTK | 0.76085779 |
| 66 | NME2 | 0.75772422 |
| 67 | PRKCD | 0.74396837 |
| 68 | PTK6 | 0.69784838 |
| 69 | KSR2 | 0.68686861 |
| 70 | DAPK2 | 0.66734394 |
| 71 | PRKG2 | 0.66422216 |
| 72 | TEC | 0.66368289 |
| 73 | MARK3 | 0.65864518 |
| 74 | MAP3K5 | 0.65408743 |
| 75 | ABL1 | 0.64368771 |
| 76 | CAMK1D | 0.63732949 |
| 77 | EGFR | 0.62234585 |
| 78 | TESK2 | 0.62151932 |
| 79 | YES1 | 0.61530172 |
| 80 | STK3 | 0.61418722 |
| 81 | ERBB3 | 0.61118017 |
| 82 | MAPK15 | 0.59908816 |
| 83 | IRAK2 | 0.59831438 |
| 84 | MARK2 | 0.59021285 |
| 85 | MAP2K6 | 0.58914196 |
| 86 | STK24 | 0.58052713 |
| 87 | TYRO3 | 0.57745504 |
| 88 | GRK7 | 0.57051682 |
| 89 | SIK3 | 0.56674623 |
| 90 | MOS | 0.56161710 |
| 91 | PKN1 | 0.55028555 |
| 92 | MAPKAPK2 | 0.53916617 |
| 93 | RPS6KC1 | 0.51411934 |
| 94 | RPS6KL1 | 0.51411934 |
| 95 | RPS6KA2 | 0.50965053 |
| 96 | PRKD2 | 0.50529354 |
| 97 | LRRK2 | 0.48311578 |
| 98 | MAPK7 | 0.47718693 |
| 99 | TESK1 | 0.47025426 |
| 100 | PRKCQ | 0.46971290 |
| 101 | HIPK2 | 0.45476058 |
| 102 | STK38 | 0.45337208 |
| 103 | CAMKK2 | 0.45242468 |
| 104 | STK10 | 0.45019028 |
| 105 | MAP3K1 | 0.44980972 |
| 106 | BCR | 0.44591956 |
| 107 | NUAK1 | 0.43832993 |
| 108 | ICK | 0.42342301 |
| 109 | PAK4 | 0.41456284 |
| 110 | INSRR | 0.39000971 |
| 111 | FYN | 0.38955571 |
| 112 | NLK | 0.37691887 |
| 113 | MAP3K2 | 0.35260692 |
| 114 | PDK2 | 0.34988696 |
| 115 | MAP2K3 | 0.34364604 |
| 116 | MAPK12 | 0.34222584 |
| 117 | BMPR1B | 0.33869175 |
| 118 | TTN | 0.33138954 |
| 119 | DAPK3 | 0.33118390 |
| 120 | CDK6 | 0.32473196 |
| 121 | FLT3 | 0.30031833 |
| 122 | MAP3K11 | 0.29981677 |
| 123 | PRKAA2 | 0.29909567 |
| 124 | GSK3A | 0.29905742 |
| 125 | ADRBK2 | 0.29510759 |
| 126 | DYRK1B | 0.29246738 |
| 127 | RPS6KA5 | 0.28970908 |
| 128 | PDGFRB | 0.28681413 |
| 129 | SIK2 | 0.25626797 |
| 130 | PIK3CG | 0.25043158 |
| 131 | IGF1R | 0.24370215 |
| 132 | PRKCE | 0.24126182 |
| 133 | RPS6KA6 | 0.24014036 |
| 134 | RPS6KA1 | 0.24002641 |
| 135 | EPHB2 | 0.23222239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.30598322 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.26161133 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.20275839 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.89988958 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.89340609 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.85176942 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.52489838 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.51475402 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.47226417 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 2.33258347 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.32284335 |
| 12 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.24288540 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.24228375 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.16673535 |
| 15 | Measles_Homo sapiens_hsa05162 | 2.09733517 |
| 16 | Malaria_Homo sapiens_hsa05144 | 2.08795588 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.04119088 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.02229367 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 1.96972326 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.95113070 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.86981575 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.85563164 |
| 23 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.72990815 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.69857672 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.68069092 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.63458406 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.56778081 |
| 28 | Apoptosis_Homo sapiens_hsa04210 | 1.56098531 |
| 29 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.51762958 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.49959969 |
| 31 | Lysosome_Homo sapiens_hsa04142 | 1.48463427 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.47406541 |
| 33 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39719455 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.38906237 |
| 35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38206964 |
| 36 | Phagosome_Homo sapiens_hsa04145 | 1.37038023 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29826879 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.28296612 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.25057026 |
| 40 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.09600237 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.09209587 |
| 42 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.07350508 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04787492 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.00822718 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98356543 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 0.97304852 |
| 47 | Amoebiasis_Homo sapiens_hsa05146 | 0.95565275 |
| 48 | Prion diseases_Homo sapiens_hsa05020 | 0.92155753 |
| 49 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.87650004 |
| 50 | Other glycan degradation_Homo sapiens_hsa00511 | 0.86533148 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84618752 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84081857 |
| 53 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.78334203 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78232739 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.77458717 |
| 56 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75181690 |
| 57 | Bladder cancer_Homo sapiens_hsa05219 | 0.74977034 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73264704 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72617731 |
| 60 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.72567357 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72368380 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71212631 |
| 63 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.69619953 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68153491 |
| 65 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63076913 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59461089 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58757707 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57359085 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56798767 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56429844 |
| 71 | Mineral absorption_Homo sapiens_hsa04978 | 0.55366298 |
| 72 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54641619 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51820927 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49009656 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48604752 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46514530 |
| 77 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.44981621 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44457097 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44437322 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44373032 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.44137684 |
| 82 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.43479739 |
| 83 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41973511 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41741678 |
| 85 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40783269 |
| 86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40255340 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39202993 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38213601 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37721442 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35581447 |
| 91 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.35247466 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35063768 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35031482 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34748057 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33407542 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30303176 |
| 97 | Adherens junction_Homo sapiens_hsa04520 | 0.30250149 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30085570 |
| 99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30048476 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28756781 |
| 101 | ABC transporters_Homo sapiens_hsa02010 | 0.27515405 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.27310796 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26743261 |
| 104 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.26060516 |
| 105 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.24327022 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.21898477 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.21220890 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20971451 |
| 109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.20669073 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20586625 |
| 111 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.20375932 |
| 112 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.20321601 |
| 113 | Focal adhesion_Homo sapiens_hsa04510 | 0.18427612 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.17905632 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17314246 |
| 116 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.16308101 |
| 117 | Prostate cancer_Homo sapiens_hsa05215 | 0.14027117 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.13050350 |
| 119 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.12848447 |
| 120 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.12734077 |

